Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)

This study has been completed.
Information provided by Bristol-Myers Squibb

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Additional conditions recognized in this trial
			Melanoma
2		More general conditions related to this trial
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms, Germ Cell and Embryonal
			Neoplasms, Nerve Tissue
			Neuroectodermal Tumors
			Neuroendocrine Tumors
			Nevi and Melanomas
3		Interventions listed in this trial
			Ipilimumab
4		Sponsors listed in this trial
			Bristol-Myers Squibb